Setdb1 represses anti-tumor immunity and tertiary lymphoid structures in hepatocellular carcinoma

Study limitation reported by the research below: “impact flag 'practice changing' is applied cautiously — findings are preclinical; clinical impact is potential, not yet demonstrated.”